|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61P 35/02 |
| (11) | Patento numeris | 3284755 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17189927.1 |
| Europos patento paraiškos padavimo data | 2011-12-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201061428699 P | 2010-12-30 | US | |
| 201161470382 P | 2011-03-31 | US | |
| 201161470406 P | 2011-03-31 | US | |
| 201161485104 P | 2011-05-11 | US |
| (72) |
ELIAS, Kathleen Ann, US
LANDES, Gregory, US
SINGH, Shweta, US
KORVER, Wouter, US
DRAKE, Andrew Walling, US
HAAK-FRENDSCHO, Mary, US
SNELL, Gyorgy Pal, US
BHASKAR, Vinay, US
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (54) | CONJUGATED ANTI-CD38 ANTIBODIES |
| CONJUGATED ANTI-CD38 ANTIBODIES |